Edited By: B.L. Strom, USA; V. Lo Re, USA; Olaf H. Klungel, The Netherlands; B.J. Park, Korea
Pharmacoepidemiology and Drug Safety is an international forum for the communication and evaluation of data, methods and opinion in the combined disciplines of pharmacology and epidemiology. We embrace scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. The journal publishes papers covering pharmacovigilance, post-marketing surveillance, pharmaeconomics, patient safety, comparative effectiveness of different pharmaceuticals and medical devices, risk management, and pharmacoepidemiological methods.
Journal Metrics
- 3.7CiteScore
- 2.4Journal Impact Factor
- 29%Acceptance rate
- 40 days Submission to first decision

Online publication from 2024
Pharmacoepidemiology and Drug Safety will be published in online-only format effective with the 2024 volume. This is a proactive move towards reducing the environmental impact caused by the production and distribution of printed journal copies and will allow the journal to invest in further innovation, digital development, and sustainability measures. All color images will now be reproduced digitally and published free of charge. Printed copies may be obtained through a print-on-demand service.
ISPE - International Society for Pharmacoepidemiology
PDS is the Official Journal of the International Society for Pharmacoepidemiology (ISPE)
Members, be sure to receive your free online access to the journal.
Join ISPE today to gain journal access tomorrow.
On the Cover
Articles
Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)—A Framework of Diversity and Fairness in Pharmacoepidemiologic Research
-  20 July 2025
How COVID-19 Treatment in Pregnancy Reflects Healthcare Utilization During a Pandemic: A Two-Stage Individual Participant Data Meta-Analysis Combining Case-Based Registries
-  16 July 2025
High‐Dimensional Disease Risk Score for Dealing With Residual Confounding Bias in Estimating Treatment Effects With a Survival Outcome
-  6 July 2025
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
-  483-486
-  10 December 2001
The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months†
-  726-735
-  9 August 2006
The reporting odds ratio and its advantages over the proportional reporting ratio
-  519-523
-  11 August 2004
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
-  3-10
-  6 February 2002
Quantitative signal detection using spontaneous ADR reporting
-  427-436
-  8 April 2009
Recent issues
- Volume 34, Issue 8August 2025
- Volume 34, Issue 7July 2025
- Volume 34, Issue 6June 2025
- Volume 34, Issue 5May 2025